Need Help? Call : (310) 914-5007
Need Help? Call : (310) 914-5007
The Law Offices of Frank R. Cruz announces an investigation of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN) on behalf of investors concerning the Company’s possible violations of federal securities laws.
What Is The Investigation About?
On June 2, 2026, the FDA published a warning letter addressed to Medline regarding “significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals,” stating that, among other things, Medline “failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications.”
On this news, Medline’s stock price fell $2.56, or 7.16%, to close at $33.19 per share on June 2, 2026, thereby injuring investors.
If you suffered a loss on your Medline Industries, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.
© 2026 The Law Offices of Frank R. Cruz. A Professional Services Corporation.
Website Designed & Developed By ITIFFY Consultants.